2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[(2,5-dihydro-2,4-dimethyl-5-oxo-1-phenyl-1H-pyrazol-3-yl)methyl]-5-ethyl- (5767-61-3)

Identification
Name:	2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[(2,5-dihydro-2,4-dimethyl-5-oxo-1-phenyl-1H-pyrazol-3-yl)methyl]-5-ethyl-
Synonyms:	Barbituric acid, 5-[(2,4-dimethyl-5-oxo-1-phenyl-3-pyrazolin-3-yl)methyl]-5-ethyl-(7CI,8CI)
CAS:	5767-61-3
Molecular Formula:	C18H20 N4 O4
Molecular Weight:	459.5336
InChI:	InChI=1/C28H29NO5/c1-17-24(27(31)32-12-11-18-7-5-4-6-8-18)25(19-9-10-22-23(13-19)34-16-33-22)26-20(29-17)14-28(2,3)15-21(26)30/h4-10,13,25,29H,11-12,14-16H2,1-3H3
Molecular Structure:
Properties
Flash Point:	329°C
Boiling Point:	620.4°Cat760mmHg
Density:	1.27g/cm³
Refractive index:	1.626
Flash Point:	329°C
Safety Data

Other Product

2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylene]-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-5-ethyl-, mixt. with 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one
2,4,6(1H,3H,5H)-Pyrimidinetrione,1,3-dimethyl-5-nitroso-,4-[2-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]hydrazone]
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-3-methyl-1-[2-(4-morpholinyl)ethyl]-5-phenyl-
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-(1-methylethyl)- 5-(2-propenyl)-,mixt. with 4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-1-methyl-5-phenyl-3-(2-propen-1-yl)-
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-(2- butenyl)-5-ethyl-,mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione and 4-(dimethylamino)-1,2-dihydro-1,- 5-dimethyl-2-phenyl-3H-pyrazol-3-one
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- phenyl-,compounds,mixt. with 1-[(3,4-dimethoxyphenyl)methyl]-6,7- dimethoxyisoquinoline hydrochloride and 4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one
Benzoic acid,compounds,sodium salt,mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one,5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione and sodium [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl- 1H-pyrazol-4-yl)methylamino]- methanesulfonate
2,4,6(1H,3H,5H)-Pyrimidinetrione,1,3-dimethyl-5-nitroso-, 4-[2-(2-acetyl-3-oxo-1-buten-1-yl)hydrazone]
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[3-[4-(dimethylamino)phenyl]-1-oxo-2-propenyl]-
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[[[4-[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)azo]-2,5-dimethylphenyl]imino]methyl]-
Acetamide,N-(4-ethoxyphenyl)-,mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-1-[2-(4-morpholinyl)ethyl]-5-phenyl-
Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one,N-(4-ethoxyphenyl)acetamide and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5-[4-(4-morpholinyl)-2-butyn-1-yl]-
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-1-methyl-5-(3-phenyl-2-propenyl)-
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[2-(4-morpholinyl)ethyl]-5-phenyl-, hydrochloride (1:1)
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5-[4-(1-pyrrolidinyl)-2-butyn-1-yl]-
Ergotaman-3',6',18-trione,9,10-dihydro-12'- hydroxy-2'-methyl-5'-(phenylmethyl)-,(5'R,- 10R)-,mixt. with 1,2-dihydro-1,5-dimethyl-4-(1-methylethyl)- 2-phenyl-3H-pyrazol-3-one,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione and 5-(2-methylpropyl)-5-(2-propenyl)- 2,4,6(1H,3H,5H)-pyrimidinetrione